Equity Research, Broker Reports, and media content on Sensyne Health Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Sensyne Health Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Sensyne Health Plc

Company Profile

  • Personnel
  • Paul Drayson, CEO
  • Lorimer Headley, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Sensyne Health Plc. We currently have 103 research reports from 4 professional analysts.

  • Open: 172p
  • Range Today: 165/177p
  • 52 Week: 26.0/190p
  • Daily Volume: 67.2k
  • Daily Liquidity: (0.05%)
  • # Shares: 128.6m
  • Market Cap: £266.5m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
12Mar21 07:00 RNS Agreement with the UK DHSC
01Mar21 07:00 RNS Board Changes
01Mar21 07:00 RNS SYNE-COV Achieves UK Regulatory Approval
10Feb21 14:06 RNS Second Price Monitoring Extn
10Feb21 14:00 RNS Price Monitoring Extension
09Feb21 07:48 RNS Sensyne licenses MagnifEye technology to Excalibur
05Feb21 14:57 RNS Holdings in Company
  • Frequency of research reports


  • Research reports on

    Sensyne Health Plc

  • Providers covering

    Sensyne Health Plc